Originally published as JCO Early Release 10.1200/JCO.2007.15.2108 on May 12 2008
Journal of Clinical Oncology, Vol 26, No 19 (July 1), 2008: pp. 3248-3258
© 2008 American Society of Clinical Oncology.
Accuracy and Surgical Impact of Magnetic Resonance Imaging in Breast Cancer Staging: Systematic Review and Meta-Analysis in Detection of Multifocal and Multicentric Cancer
Nehmat Houssami,
Stefano Ciatto,
Petra Macaskill,
Sarah J. Lord,
Ruth M. Warren,
J. Michael Dixon,
Les Irwig
From the Screening and Test Evaluation Program, School of Public Health; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia; Department of Diagnostic Imaging, Centro per lo Studio e la Prevenzione Oncologica, Istituto Scientifico della Regione Toscana, Florence, Italy; Department of Radiology, Addenbrooke's Hospital, Cambridge, United Kingdom; and the Edinburgh Breast Unit, Western General Hospital, Edinburgh, Scotland
Corresponding author: Nehmat Houssami, MBBS, PhD, FAFPHM, Screening and Test Evaluation Program, School of Public Health (A27), University of Sydney, Sydney 2006, Australia; e-mail: nehmath{at}med.usyd.edu.au
Purpose We review the evidence on magnetic resonance imaging (MRI) in staging the affected breast to determine its accuracy and impact on treatment.
Methods Systematic review and meta-analysis of the accuracy of MRI in detection of multifocal (MF) and/or multicentric (MC) cancer not identified on conventional imaging. We estimated summary receiver operating characteristic curves, positive predictive value (PPV), true-positive (TP) to false positive (FP) ratio, and examined their variability according to quality criteria. Pooled estimates of the proportion of women whose surgery was altered were calculated.
Results Data from 19 studies showed MRI detects additional disease in 16% of women with breast cancer (N = 2,610). MRI incremental accuracy differed according to the reference standard (RS; P = .016) decreasing from 99% to 86% as the quality of the RS increased. Summary PPV was 66% (95% CI, 52% to 77%) and TP:FP ratio was 1.91 (95% CI, 1.09 to 3.34). Conversion from wide local excision (WLE) to mastectomy was 8.1% (95% CI, 5.9 to 11.3), from WLE to more extensive surgery was 11.3% in MF/MC disease (95% CI, 6.8 to 18.3). Due to MRI-detected lesions (in women who did not have additional malignancy on histology) conversion from WLE to mastectomy was 1.1% (95% CI, 0.3 to 3.6) and from WLE to more extensive surgery was 5.5% (95% CI, 3.1 to 9.5).
Conclusion MRI staging causes more extensive breast surgery in an important proportion of women by identifying additional cancer, however there is a need to reduce FP MRI detection. Randomized trials are needed to determine the clinical value of detecting additional disease which changes surgical treatment in women with apparently localized breast cancer.
published online ahead of print at www.jco.org on May 12, 2008
Supported in part by National Health and Medical Research Council program Grant No. 402764 to the Screening and Test Evaluation Program.
Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. C. Partridge, W. B. DeMartini, B. F. Kurland, P. R. Eby, S. W. White, and C. D. Lehman
Quantitative Diffusion-Weighted Imaging as an Adjunct to Conventional Breast MRI for Improved Positive Predictive Value
Am. J. Roentgenol.,
December 1, 2009;
193(6):
1716 - 1722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Brennan, N. Houssami, S. Lord, P. Macaskill, L. Irwig, J. M. Dixon, R. M.L. Warren, and S. Ciatto
Magnetic Resonance Imaging Screening of the Contralateral Breast in Women With Newly Diagnosed Breast Cancer: Systematic Review and Meta-Analysis of Incremental Cancer Detection and Impact on Surgical Management
J. Clin. Oncol.,
November 20, 2009;
27(33):
5640 - 5649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Lord, L. Irwig, and P. M. M. Bossuyt
Using the Principles of Randomized Controlled Trial Design to Guide Test Evaluation
Med Decis Making,
September 1, 2009;
29(5):
E1 - E12.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Morrow and J. R. Harris
More Mastectomies: Is This What Patients Really Want?
J. Clin. Oncol.,
September 1, 2009;
27(25):
4038 - 4040.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Jansen, A. Shimauchi, L. Zak, X. Fan, A. M. Wood, G. S. Karczmar, and G. M. Newstead
Kinetic Curves of Malignant Lesions Are Not Consistent Across MRI Systems: Need for Improved Standardization of Breast Dynamic Contrast-Enhanced MRI Acquisition
Am. J. Roentgenol.,
September 1, 2009;
193(3):
832 - 839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Houssami and D. F. Hayes
Review of Preoperative Magnetic Resonance Imaging (MRI) in Breast Cancer: Should MRI Be Performed on All Women with Newly Diagnosed, Early Stage Breast Cancer?
CA Cancer J Clin,
September 1, 2009;
59(5):
290 - 302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Houssami
Overview of the Evidence on MRI-guided Local Staging of Breast Cancer and Effect on Treatment
ASCO Educational Book,
January 1, 2009;
2009(1):
45 - 50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Solin
The Effect of Breast Magnetic Resonance Imaging on Long-term Outcome after Breast Conservation Treatment with Radiation
ASCO Educational Book,
January 1, 2009;
2009(1):
51 - 54.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|